HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN 50 ADVANCED RESISTANT HODGKINS-DISEASE PATIENTS - AN ITALIAN STUDY-GROUP REPORT

被引:161
|
作者
CARELLA, AM
CONGIU, AM
GAOZZA, E
MAZZA, P
RICCI, P
VISANI, G
MELONI, G
CIMINO, G
MANGONI, L
COSER, P
CETTO, GL
CIMINO, R
ALESSANDRINO, EP
BRUSAMOLINO, E
SANTINI, G
TURA, S
MANDELLI, F
RIZZOLI, V
BERNASCONI, C
MARMONT, AM
机构
[1] INST HEMATOL,BOLOGNA,ITALY
[2] INST HEMATOL,ROME,ITALY
[3] OSPED CIVILE,DIV HEMATOL,BOLZANO,ITALY
[4] INST CLIN ONCOL,VERONA,ITALY
[5] SERV HEMATOL,NAPOLI,ITALY
[6] POLICLIN SAN MATTEO,DIV HEMATOL,PAVIA,ITALY
关键词
D O I
10.1200/JCO.1988.6.9.1411
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1411 / 1416
页数:6
相关论文
共 50 条
  • [31] AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND HIGH-DOSE CHEMOTHERAPY
    PHILIP, T
    PLOUVIER, E
    ROZENBAUM, A
    BIRON, P
    VUVAN, H
    EHRSAM, A
    BERGERAT, JP
    BEHART, C
    CORDIER, JF
    FREYCON, F
    HERVE, P
    LYON MEDICAL, 1981, 246 (15): : 137 - 148
  • [32] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    SPITZER, G
    DICKE, K
    ZANDER, AR
    JAGANNATH, S
    VELLEKOOP, L
    FREIREICH, EJ
    CANCER, 1984, 54 (06) : 1216 - 1225
  • [33] AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH RELAPSED HODGKINS-DISEASE
    ARMITAGE, JO
    BIERMAN, PJ
    VOSE, JM
    ANDERSON, JR
    WEISENBURGER, DD
    KESSINGER, A
    REED, EC
    VAUGHAN, WP
    COCCIA, PF
    PURTILO, DT
    AMERICAN JOURNAL OF MEDICINE, 1991, 91 (06): : 605 - 611
  • [34] HIGH-DOSE CYTOTOXIC THERAPY AND BONE-MARROW TRANSPLANTATION FOR RELAPSED HODGKINS-DISEASE
    JONES, RJ
    PIANTADOSI, S
    MANN, RB
    AMBINDER, RF
    SEIFTER, EJ
    VRIESENDORP, HM
    ABELOFF, MD
    BURNS, WH
    MAY, WS
    ROWLEY, SD
    VOGELSANG, GB
    WAGNER, JE
    WILEY, JM
    WINGARD, JR
    YEAGER, AM
    SARAL, R
    SANTOS, GW
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) : 527 - 537
  • [35] THE ROLE OF HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW REINFUSION IN THE TREATMENT OF HODGKINS-DISEASE
    WILLIAMS, SF
    BITRAN, JD
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1989, 3 (02) : 319 - 330
  • [36] HIGH-DOSE MELPHALAN AND AUTOLOGOUS BONE-MARROW TRANSPLANT AS TREATMENT FOR REFRACTORY HODGKINS-DISEASE
    SELBY, PJ
    MBIDDE, EK
    MAITLAND, J
    MCELWAIN, TJ
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) : 612 - 612
  • [37] AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOLLOWING HIGH-DOSE BUSULFAN AND VP-16 FOR ADVANCED NON-HODGKINS-LYMPHOMA AND HODGKINS-DISEASE
    ROSENFELD, CS
    PRZEPIORKA, D
    SCHWINGHAMMER, TL
    BUCK, DS
    BLOOM, EJ
    SHADDUCK, RK
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (05) : 317 - 321
  • [38] ACCELERATED HYPERFRACTIONATED TOTAL-LYMPHOID IRRADIATION, HIGH-DOSE CHEMOTHERAPY, AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RELAPSING PATIENTS WITH HODGKINS-DISEASE
    YAHALOM, J
    GULATI, SC
    TOIA, M
    MASLAK, P
    MCCARRON, EG
    OBRIEN, JP
    PORTLOCK, CS
    STRAUS, DJ
    PHILLIPS, J
    FUKS, Z
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) : 1062 - 1070
  • [39] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANT IN HODGKINS-DISEASE - THE ROYAL-MARSDEN-HOSPITAL EXPERIENCE
    CUNNINGHAM, D
    OBRIEN, MER
    HILL, M
    MILAN, S
    NICOLSON, M
    JONES, AL
    VINER, C
    HICKISH, T
    BLOOD, 1994, 84 (10) : A162 - A162
  • [40] INDICATIONS FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HODGKINS-DISEASE
    CARELLA, AM
    LEUKEMIA & LYMPHOMA, 1992, 7 : 21 - 22